Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Intravenous Zoledronate for the Treatment of Post-menopausal Osteoporosis
TCTR20210930001Phase 4Active, not recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronate in postmenopausal osteoporosis, sponsored by Phramongkutklao Hospital. Started Jul 2018; status: active, not recruiting.
02
Drugs
zoledronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on TCTR20210930001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210930001.